Brain Vascular Health Linked to Reproductive History
Researchers found that women with a longer window of estrogen exposure—defined as the years between their first period and menopause or ovary removal—exhibited fewer markers of cerebral small vessel disease later in life.
The study, which followed 352 women in Sweden starting at age 70, assessed participants for signs of vascular damage, including white matter hyperintensities, microbleeds, and lacunes. News-Medical reported that after adjusting for education level, number of pregnancies, and total duration of breastfeeding, women with a longer reproductive lifespan showed 8% lower odds of having two or more signs of small vessel disease for each additional year. On average, the reproductive lifespan lasted 37 years.
Hormone Therapy Associations Observed at Age 70
Participants in the study reported their history of oral contraceptive use and menopausal hormone therapy (MHT) during interviews. Data indicated that 73% of the women had used birth control pills, while 61% had used or were currently using MHT.
According to News-Medical, women who utilized menopausal hormone therapy had 59% lower odds of having a greater burden of small vessel disease. These participants also displayed better integrity of the brain’s white matter microstructure, which researchers consider an early marker of healthy brain tissue.
The most favorable results were observed in a specific subgroup: women who had used oral contraceptives during their reproductive years and later received menopausal hormone therapy. This group showed the healthiest white matter integrity and the lowest amount of cerebral small vessel disease compared to participants who had never used hormonal therapies. “What was particularly striking was that the most favorable vascular brain health was observed among women who had used oral contraceptives during their reproductive years and later received menopausal hormone therapy,” said Anna Marseglia, PhD, of Karolinska Institutet. She added, “Estrogen is known to have protective effects on both neuronal cells and blood vessels in the brain.”
Study Limitations and Clinical Constraints
While the findings indicate a statistical association, the researchers noted that the study does not prove that estrogen exposure directly causes better brain health; establishing a causal link would require clinical trials.
The study faced several constraints. Because hormone use was self-reported during interviews, the results may be subject to recall bias. Researchers also lacked detailed information on medication use, and they were unable to track individual hormone levels throughout the participants’ lives.
Questions About Hormonal Exposure and Brain Aging
How did researchers measure cerebral small vessel disease?
Participants underwent MRI brain scans at ages 70 and 75. Researchers evaluated these scans for four specific indicators: white matter hyperintensities, microbleeds, small fluid-filled cavities known as lacunes, and the enlargement of spaces surrounding blood vessels.
Why is this research considered significant for dementia risk?
Women are affected by Alzheimer’s disease more often than men, a trend that may be linked to fluctuations in estrogen levels over time. By examining how reproductive and hormonal history correlates with cerebrovascular health, researchers aim to better understand the mechanisms behind brain aging and dementia. She further observed, “The number of incident dementia cases in women will surpass that of men by 233,000 by 2060.”
How does this study compare to the broader field of neuroimaging? While the Neurology study focuses on vascular markers, other research is investigating direct brain function. The University of Delaware’s Mechanical Neuroimaging Lab, located at the Center for Biomedical and Brain Imaging and directed by Curtis Johnson, PhD, has utilized Magnetic Resonance Elastography to detect hormone-related changes in specific brain regions. As researchers continue to explore whether hormonal fluctuations affect brain function, it remains unclear if these vascular findings translate into measurable cognitive performance differences across the lifespan.
Worth a look